Central Drugs Standard Control Organisation (CDSCO)

The Haryana-based pharmaceutical manufacturing the cough syrup.

CDSCO Report Reveals Alarming Contamination Levels In Indian Allergy And Cough Syrups

BY Outlook Web Desk

A child being given a vaccine.

Bharat Biotech Recalls Batch Of Typhoid Vaccines After Being Flagged Over Quality Issues

BY Outlook Web Desk

Pharma sector

Indian Drug Regulations Should Match Global Standards: NITI Ayog

BY Outlook Web Desk

There are around 700 pharmaceutical companies in Himachal Pradesh (Representative Image)

Himachal Pradesh: How Spurious Drugs Have Brought Bad Name, Regulatory Spotlight On State’s Famed Pharma Industry

BY Ashwani Sharma

Health authorities of Gambia and Uzbekistan have recently linked deaths of children there to syrups made in India. Such incidents risk denting India's image as the 'pharmacy of the world'.

India Takes Pride In Being ‘Pharmacy Of The World’ But Cough Syrup, Eye Drop Deaths Tell A Different Story

Dok-1 Max Syrup produced by Noida-based Marion Biotech

Uzbekistan Deaths: India Starts Probing Marion Biotech, What We Know So Far Of Syrup Controversy

BY Outlook Web Desk

COVAXIN

50 mn Doses Of Covaxin Set To Expire Early 2023 Due To Poor Off Take

BY PTI

Advertisement

The four 'contaminated' and 'substandard' cough syrups that WHO has linked to an Indian manufacturer

Centre Starts Probe After WHO Claims Indian Cough Syrups Behind 66 Deaths In The Gambia

BY Outlook Web Desk

Representational Image

Govt Panel Recommends EUA For Covid Vaccine Covovax For 12-17 Age Group

BY PTI

8 Vaccines, 4 Treatments in India’s Covid-19 Arsenal

8 Vaccines, 4 Treatments in India’s Covid-19 Arsenal

BY Outlook Web Desk

CDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine Covovax

CDSCO Panel Recommends Emergency Use Authorisation For SII’s Covid Vaccine Covovax

BY Outlook Web Desk

Covid-19: India Gets Two More Vaccines Corbevax, Covovax

Covid-19: India Gets Two More Vaccines Corbevax, Covovax

BY Outlook Web Desk

Covaxin: Bharat Biotech's Covid-19 Shot Gets Shelf Life Extension Up To 12 Months

Covaxin: Bharat Biotech's Covid-19 Shot Gets Shelf Life Extension Up To 12 Months

BY Outlook Web Desk